Sandoz Lecture Migraine—A Biochemical Disorder?

  • J. N. Cumings

Abstract

The Sandoz Lectures given thus far have been devoted to an historical survey by one of the originators of the Migraine Trust, to aspects of pharmacology in relation to migraine by an acknowledged expert, and to a clinical review by one of America’s foremost clinicians. All three have been founded on fact together with personal observations; now, however, it has been suggested that biochemical features be the subject of the Lecture. This opens the field for speculation, for there are few undoubted facts available.

Keywords

Platelet Aggregation Migraine Patient MANDELIC Acid World Federation Platelet Aggre 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anthony, M., Hinterberger, H. and Lance, J. W. (1967). Plasma serotonin in migraine and stress. Arch. Neurol., Chicago, 16, 544–552.CrossRefGoogle Scholar
  2. Anthony, M. and Lance, J. W. (1969). Monoamine oxidase inhibition in the treatment of migraine. Arch. Neurol., Chicago, 21, 263–268.CrossRefGoogle Scholar
  3. Blau, J. N., Horsfield, D., Quick, J. and Cumings, J. N. (1967). The production of migraine and biochemical changes in induced attacks. In Background to Migraine, page 146. London: William Heinemann Medical Books.Google Scholar
  4. Brodie, B. B., Maickel, R. P. and Westermann, E. O. (1961). Action of reserpine on pituitary-adrenocortical system through possible action on hypothalamus. In Regional Neurochemistry, Physiology and Pharmacology of the Nervous System. Proceedings of the Fourth International Neurochemical Symposium, Italy, page 351. Oxford: Pergamon Press.Google Scholar
  5. Campbell, Dorothy A., Hay, E. M. and Tonks, Eva M. (1951). An investigation of the salt and water balance in migraine. Brit. med. J. 2, 1424–1429.CrossRefGoogle Scholar
  6. Curran, D. A., Hinterberger, H. and Lance, J. W. (1965). Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxymethoxymandelic acid excretion in normal and migrainous subjects. Brain, 88, 997–1010.CrossRefGoogle Scholar
  7. Curzon, G., Barrie, M. and Wilkinson, M. I. P. (1969). Relationship between headache and amine changes after administration of reserpine to migrainous patients. J. Neurol. Neurosurg. Psychiat. 32, 555–561.CrossRefGoogle Scholar
  8. Curzon, G., Theaker, Prunella and Phillips, B. (1966). Excretion of 5-hydroxyindolyl acetic acid (5-HIAA) in migraine. J. Neurol. Neurosurg. Psychiat. 29, 85–90.CrossRefGoogle Scholar
  9. da Prada, M. and Pletscher, A. (1970). Mechanisms of uptake, storage and release of 5-hydroxytryptamine in blood platelets. Proceedings of International Migraine-Headache Symposium, Florence, page 101, World Federation of Neurology.Google Scholar
  10. Garattini, S. and Valzelli, L. (1965). Serotonin. Amsterdam: Elsevier Publishing Company.Google Scholar
  11. Giacovazzo, M. (1970). Pathophysiological bases for a new treatment of headache. Proceedings of International Migraine-Headache Symposium, Florence, page 32, World Federation of Neurology.Google Scholar
  12. Hanington, E. (1967). Preliminary report on tyramine headache. Brit. med. J. 2, 550–551.CrossRefGoogle Scholar
  13. Hanington, E. (1970). Dietary factors in migraine. In Kliniske aspekter migrœneforskningen, page 31 (Redigeret af: Axel Klee og Karen Ulrich) Symposium af holdt af Dansk Migrœneselskab og DAK-Laboratoriet, Kobenhavn, Udgivet af Danmarks Apotekerforening.Google Scholar
  14. Hanington, E. and Harper, A. Murray (1970). Hypothesis for migraine. In Kliniske aspekter i migraeneforskningen, page 39 (Redigeret af: Axel Klee og Karen Ulrich), Symposium afholdt af Dansk Migrœneselskab og DAK-Laboratoriet, Kobenhavn, Udgivet af Danmarks Apotekerforening.Google Scholar
  15. Harper, A. Murray (1970). Experimental studies of tyramine and noradrenaline on the cerebral and extracerebral circulations. In Kliniske aspekter i migrœneforskningen, page 39 (Redigeret af: Axel Klee og Karen Ulrich), Symposium af holdt af Dansk Migrœneselskab og DAK-Laboratoriet, Kobenhavn, Udgivet af Danmarks Apotekerforening.Google Scholar
  16. Hilton, Barbara P. and Cumings, J. N. (1971). An assessment of platelet aggregation induced by 5-hydroxytryptamine. J. clin. Path. (In Press.)Google Scholar
  17. Holmsen, H. and Day, H. J. (1970). The selectivity of the thrombin-induced platelet release reaction: Subcellular localization of released and retained constituents. J. Lab. clin. Med. 75, 840–855.Google Scholar
  18. Kimball, R. W., Friedman, A. P. and Vallejo, E. (1960). Effect of serotonin in migraine patients. Neurology, Minneap. 10, 107–111.CrossRefGoogle Scholar
  19. Lance, J. W. (1969). The Mechanism and Management of Headache, page 102. London: Butterworths.Google Scholar
  20. Murray, K. (1970). Nucleotide “maps” of digests of deoxyribonucleic acid. Biochem. J. 118, 831–841.Google Scholar
  21. Owman, C. and Nielsen, K. C. (1970). The role of amine mechanisms in the vaso-motor regulation of cranial arteries. Proceedings of International Migraine-Headache Symposium, Florence, page 31, World Federation of Neurology.Google Scholar
  22. Page, Irvine H. (1968). Serotonin. Chicago: Year Book Medical Publishers, Inc.Google Scholar
  23. Poller, L. (1970). Relation between oral contraceptive hormones and blood clotting. J. Clin. Path. 23, suppl. (Ass. Clin. Path.), 3, 67–74.Google Scholar
  24. Pratt, R. T. C. (1967). The Genetics of Neurological Disorders, page 122. London: Oxford University Press.Google Scholar
  25. Salzman, E. W. (1962). Effect of reserpine on hemostasis in the rabbit. Thromb. Diath. Hœmorrh. 7, 507–513.Google Scholar
  26. Sandler, M., Youdim, M. B. H., Southgate, J. and Hanington, E. (1970). The role of tyramine in migraine: Some possible biochemical mechanisms. In Background to Migraine, page 103. London: William Heinemann Medical Books.Google Scholar
  27. Schumacher, G. A. and Wolff, H. G. (1941). Experimental studies on headache; contrast of histamine headache with headache of migraine and that associated with hypertension; contrast of vascular mechanisms in preheadache and in headache phenomena of migraine. Arch. Neurol. Psychiat., Chicago, 45, 199–214.CrossRefGoogle Scholar
  28. Sicuteri, F., Buffoni, F., Anselmi, B. and del Bianco, P. L. (1970). Migraine as infradian rhythmical disease: a research on platelets monoamino-oxidase. Proceedings of International Migraine-Headache Symposium, Florence, page 93, World Federation of Neurology.Google Scholar
  29. Sicuteri, F., Lombardi, V., Michelacci, S. and Franchi, G. (1961a). Variazioni dinimiche del tromboelastogramma durante le crisi di cefalea. Vascolare ipocoagulabilità come probabile espressione di liberazione di eparina dai mastociti dei tessuti. Settim. med. 49, 835–839.Google Scholar
  30. Sicuteri, F., Testi, A. and Anselmi, B. (1961b). Biochemical investigations in headache: increase in the hydroxyindoleacetic acid excretion during migraine attacks. Int. Arch. Allergy, 19, 55–58.CrossRefGoogle Scholar
  31. Tretyakova, K. A. and Fets, A. N. (1969). Total blood serotonin concentration in patients with migraine during and between attacks. Zh. Nevropat. Psikhiat. Korsakov, 69, 831–835.Google Scholar
  32. Zweifler, A. J. (1967). Impairment of platelet function and thrombus growth in reserpine-treated rabbits. J. Lab. clin. Med. 70, 16–22.Google Scholar
  33. Zweifler, A. J. and Boddy, J. (1965). Thrombus propagation in the carotid artery of the rabbit. A method of study. Arch. Path., Chicago, 80, 636–640.Google Scholar

Copyright information

© Springer Science+Business Media New York 1971

Authors and Affiliations

  • J. N. Cumings

There are no affiliations available

Personalised recommendations